Retractable Technologies, Inc. (NYSEAMERICAN:RVP) insider Thomas J. Shaw purchased 18,700 shares of the stock in a transaction on Tuesday, April 3rd. The stock was acquired at an average cost of $0.88 per share, with a total value of $16,456.00. Following the completion of the purchase, the insider now directly owns 13,380,888 shares of the company’s stock, valued at $11,775,181.44. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website.
Shares of NYSEAMERICAN:RVP opened at $0.88 on Friday. Retractable Technologies, Inc. has a 12 month low of $0.54 and a 12 month high of $1.48.
Retractable Technologies (NYSEAMERICAN:RVP) last issued its quarterly earnings data on Monday, April 2nd. The company reported ($0.04) EPS for the quarter. The firm had revenue of $9.51 million for the quarter. Retractable Technologies had a negative net margin of 0.64% and a negative return on equity of 3.58%.
COPYRIGHT VIOLATION WARNING: “Retractable Technologies, Inc. (RVP) Insider Purchases $16,456.00 in Stock” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.tickerreport.com/banking-finance/3338256/retractable-technologies-inc-rvp-insider-purchases-16456-00-in-stock.html.
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare industry in the United States and internationally. Its principal products comprise VanishPoint 0.5mL insulin syringes; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; EasyPoint needles; VanishPoint blood collection tube holders; VanishPoint IV safety catheters; small diameter tube adapters; allergy trays; Patient Safe syringes; Patient Safe Luer caps; and VanishPoint blood collection sets, as well as VanishPoint autodisable syringes.
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.